{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:12:47Z","timestamp":1789002767347,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare the risks of surgical site infection (SSI) and postoperative complications after acetabular fracture open reduction internal fixation (ORIF) in patients receiving topical intrawound antibiotic powder compared with those not receiving antibiotic powder (control group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Level I trauma center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Intervention:<\/jats:title>\n                    <jats:p>We reviewed 789 acetabular fracture ORIF cases from 2010 to 2019 at our institution, with mean follow-up of 18 months (3\u2013112 months). Overall, 326 patients comprised the control group and 463 received topical antibiotic powder (294 vancomycin and 169 vancomycin\/tobramycin).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measurement:<\/jats:title>\n                    <jats:p>The study groups were compared for risk of SSI, seroma formation, wound dehiscence, acute kidney injury (AKI), and other postoperative complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were 63 total SSI (8.0%), 50 (6.3%) deep SSI and 13 suprafascial SSI (1.6%) cases. There was no difference in the risk of total SSI (8.3% vs. 7.8%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.80) or deep SSI (6.1% vs. 6.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.64). This was confirmed by multivariate analysis adjusting for covariates (odds ratio = 0.93; 95% confidence interval, 0.52\u20131.67;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.80). Similar results were demonstrated when comparing the control group with the vancomycin and vancomycin\/tobramycin subgroups. The control group and antibiotic powder groups had similar risks of all outcomes of interest, including seroma formation (1.8% vs. 1.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 1.00), wound dehiscence (1.2% vs. 2.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.42), total AKI (5.2% vs. 8.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.12), and RIFLE classification AKI (injury; 0.9% vs. 2.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.50).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The addition of topical intrawound antibiotic powder, whether vancomycin alone or vancomycin\/tobramycin before closure, does not reduce the risk of SSI after acetabular fracture ORIF compared with standard normal saline irrigation alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000001943","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T01:00:14Z","timestamp":1599267614000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Intrawound Antibiotic Powder in Acetabular Fracture Open Reduction Internal Fixation Does Not Reduce Surgical Site Infections"],"prefix":"10.1097","volume":"35","author":[{"given":"Kyle H.","family":"Cichos","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay A.","family":"Spitler","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Quade","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Ponce","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, UAB School of Public Health, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie S.","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BRS.0000000000001371","article-title":"Intrawound vancomycin decreases the risk of surgical site infection after posterior spine surgery: a multicenter analysis","volume":"43","author":"Devin","year":"2018","journal-title":"Spine (Phila Pa 1976)."},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1097\/BSD.0000000000000045","article-title":"Intrawound vancomycin powder decreases staphylococcal surgical site infections after posterior instrumented spinal arthrodesis","volume":"28","author":"Heller","year":"2015","journal-title":"J Spinal Disord Tech."},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00586-015-4119-3","article-title":"The use of local vancomycin powder in degenerative spine surgery","volume":"25","author":"Schroeder","year":"2016","journal-title":"Eur Spine J."},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2106\/JBJS.17.00459","article-title":"Does vancomycin powder decrease surgical site infections in growing spine surgery? a preliminary study","volume":"100","author":"Thompson","year":"2018","journal-title":"The J Bone Joint Surg Am."},{"key":"R5-20250614","first-page":"1","article-title":"Double-blind randomized clinical trial of vancomycin in spinal arthrodesis: no effects on surgical site infection","volume":"2","author":"Ludwig do Nascimento","year":"2019","journal-title":"J Neurosurg Spine."},{"key":"R6-20250614","first-page":"35","article-title":"Intrawound application of vancomycin changes the responsible germ in elective spine surgery without significant effect on the rate of infection: a randomized prospective study","volume":"102","author":"Mirzashahi","year":"2018","journal-title":"Musculoskelet Surg."},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/BRS.0000000000000015","article-title":"Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients","volume":"38","author":"Tubaki","year":"2013","journal-title":"Spine (Phila Pa 1976)."},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10195-015-0352-0","article-title":"Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study","volume":"16","author":"Singh","year":"2015","journal-title":"J Orthop Traumatol."},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/BOT.0000000000000941","article-title":"Intraoperative topical antibiotics for infection prophylaxis in pelvic and acetabular surgery","volume":"31","author":"Owen","year":"2017","journal-title":"J Orthop Trauma."},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1097\/BOT.0000000000001163","article-title":"Risk factors for early reoperation after operative treatment of acetabular fractures","volume":"32","author":"Ding","year":"2018","journal-title":"J Orthop Trauma."},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5371\/hp.2017.29.3.176","article-title":"Surgical site infection following fixation of acetabular fractures","volume":"29","author":"Iqbal","year":"2017","journal-title":"Hip Pelvis."},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/BOT.0b013e31825cf382","article-title":"Obesity, leukocytosis, embolization, and injury severity increase the risk for deep postoperative wound infection after pelvic and acetabular surgery","volume":"27","author":"Sagi","year":"2013","journal-title":"J Orthop Trauma."},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.injury.2009.11.005","article-title":"Postoperative surgical site infection following acetabular fracture fixation","volume":"41","author":"Suzuki","year":"2010","journal-title":"Injury."},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2106\/00004623-196446080-00001","article-title":"Fractures OF the acetabulum: classification and surgical approaches for open reduction: preliminary report","volume":"46","author":"Judet","year":"1964","journal-title":"J Bone Joint Surg Am."},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract."},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ki.2014.328","article-title":"The definition of acute kidney injury and its use in practice","volume":"87","author":"Thomas","year":"2015","journal-title":"Kidney Int."},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2019.00332","article-title":"Isothermal microcalorimetry detects the presence of persister cells in a Staphylococcus aureus biofilm after vancomycin treatment","volume":"10","author":"Butini","year":"2019","journal-title":"Front Microbiol."},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"e02447","DOI":"10.1128\/mBio.02447-19","article-title":"Staphylococcus aureus infects osteoclasts and replicates intracellularly","volume":"10","author":"Krauss","year":"2019","journal-title":"mBio."},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jbmr.3055","article-title":"Evidence of Staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis","volume":"32","author":"de Mesy Bentley","year":"2017","journal-title":"J Bone Miner Res."},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.arth.2018.09.056","article-title":"General assembly, prevention, local antimicrobials: proceedings of international consensus on orthopedic infections","volume":"34","author":"Baeza","year":"2019","journal-title":"J Arthroplasty."},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017CDC guideline for the prevention of surgical site infection, 2017CDC guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg."},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S1473-3099(16)30402-9","article-title":"New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective","volume":"16","author":"Allegranzi","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/neuros\/nyw097","article-title":"Does intrawound vancomycin application during spine surgery create vancomycin-resistant organism?","volume":"80","author":"Chotai","year":"2017","journal-title":"Neurosurgery."},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jspd.2019.01.005","article-title":"Local application of vancomycin in spine surgery does not result in increased vancomycin-resistant bacteria-10-year data","volume":"7","author":"Khanna","year":"2019","journal-title":"Spine Deform."},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3171\/2017.2.SPINE161310","article-title":"Prophylactic use of intraoperative vancomycin powder and postoperative infection: an analysis of microbiological patterns in 1200 consecutive surgical cases","volume":"27","author":"Adogwa","year":"2017","journal-title":"J Neurosurg Spine."},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.spinee.2018.05.036","article-title":"The impact of prophylactic intraoperative vancomycin powder on microbial profile, antibiotic regimen, length of stay, and reoperation rate in elective spine surgery","volume":"19","author":"Grabel","year":"2019","journal-title":"Spine J."},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5371\/hp.2018.30.1.37","article-title":"Intrawound vancomycin powder in primary total hip arthroplasty increases rate of sterile wound complications","volume":"30","author":"Dial","year":"2018","journal-title":"Hip Pelvis."},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2015.7.FOCUS15258","article-title":"Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review","volume":"39","author":"Ghobrial","year":"2015","journal-title":"Neurosurg Focus."},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1007\/s00167-019-05498-z","article-title":"Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties","volume":"27","author":"Hanada","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinthera.2014.05.011","article-title":"High-dose intravenous vancomycin therapy and the risk of nephrotoxicity","volume":"36","author":"Rostas","year":"2014","journal-title":"Clin Ther."},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.artd.2018.07.011","article-title":"Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection","volume":"4","author":"Patel","year":"2018","journal-title":"Arthroplast Today."},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jse.2016.07.071","article-title":"The cost effectiveness of vancomycin for preventing infections after shoulder arthroplasty: a break-even analysis","volume":"26","author":"Hatch","year":"2017","journal-title":"J Shoulder Elbow Surg."},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ajic.2017.04.012","article-title":"Considering a new domain for antimicrobial stewardship: topical antibiotics in the open surgical wound","volume":"45","author":"Edmiston","year":"2017","journal-title":"Am J Infect Control."},{"issue":"Suppl 1","key":"R34-20250614","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/BOT.0000000000000801","article-title":"Local antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: a multicenter, randomized, controlled trial (VANCO study)","volume":"31","author":"O'Toole","year":"2017","journal-title":"J Orthop Trauma."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T15:02:49Z","timestamp":1749913369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000001943","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"2020-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}